河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2015年
2期
159-161
,共3页
肺炎,吸入性%治疗结果%婴儿,新生
肺炎,吸入性%治療結果%嬰兒,新生
폐염,흡입성%치료결과%영인,신생
pneumonia,aspiration%treatment outcome%infant,newborn
目的：观察新生儿吸入性肺炎的临床特点和治疗效果。方法将新生儿吸入性肺炎患儿78例随机分为 A 组（常规抗生素＋盐酸氨溴索组）、B 组（常规抗生素＋盐酸氨溴索＋布地奈德组）、C 组（常规抗生素治疗组）各26例。治疗7 d后比较3组患儿的疗效，分析总有效率、临床症状、不良反应发生情况。结果 A 组总有效率为92．31％，B 组总有效率为96．15％，C 组总有效率为76．92％。3组总有效率比较差异无统计学意义。A、B 组呼吸困难、紫绀、肺部啰音等症状消失时间早于 C 组、住院时间少于 C 组，尤其是 B 组与 C 组治疗效果比较，B 组具有一定的优势。结论盐酸氨溴索和布地奈德的使用可以改善患儿的临床症状，用药安全可靠，有利于患儿早日康复。
目的：觀察新生兒吸入性肺炎的臨床特點和治療效果。方法將新生兒吸入性肺炎患兒78例隨機分為 A 組（常規抗生素＋鹽痠氨溴索組）、B 組（常規抗生素＋鹽痠氨溴索＋佈地奈德組）、C 組（常規抗生素治療組）各26例。治療7 d後比較3組患兒的療效，分析總有效率、臨床癥狀、不良反應髮生情況。結果 A 組總有效率為92．31％，B 組總有效率為96．15％，C 組總有效率為76．92％。3組總有效率比較差異無統計學意義。A、B 組呼吸睏難、紫紺、肺部啰音等癥狀消失時間早于 C 組、住院時間少于 C 組，尤其是 B 組與 C 組治療效果比較，B 組具有一定的優勢。結論鹽痠氨溴索和佈地奈德的使用可以改善患兒的臨床癥狀，用藥安全可靠，有利于患兒早日康複。
목적：관찰신생인흡입성폐염적림상특점화치료효과。방법장신생인흡입성폐염환인78례수궤분위 A 조（상규항생소＋염산안추색조）、B 조（상규항생소＋염산안추색＋포지내덕조）、C 조（상규항생소치료조）각26례。치료7 d후비교3조환인적료효，분석총유효솔、림상증상、불량반응발생정황。결과 A 조총유효솔위92．31％，B 조총유효솔위96．15％，C 조총유효솔위76．92％。3조총유효솔비교차이무통계학의의。A、B 조호흡곤난、자감、폐부라음등증상소실시간조우 C 조、주원시간소우 C 조，우기시 B 조여 C 조치료효과비교，B 조구유일정적우세。결론염산안추색화포지내덕적사용가이개선환인적림상증상，용약안전가고，유리우환인조일강복。
Objective To explore the clinical characteristics and curative effect of neonatal aspiration pneumonia.Methods Seventy-eight cases with neonatal aspiration pneumonia were randomly divided into three groups,each group 26 patients,C group with conventional treatment of neonatal aspiration pneumonia,A group with ambroxol hydrochloride on the basis of C group, and B group with budesonide and ambroxol hydrochloride treatment on the basis of C group.The total efficiency,the clinical symptoms and signs disappeared time,hospital stay,the incidence of adverse reactions of three groups were compared after seven days of treatment.Results The total efficiency in A group(92.31%)and B group(96.15%)were higher than that in C group(76.92%). The difference were statistically significant among three groups(P < 0.05).Breathing difficulty disappeared time,Cyanosis disappeared time and lung rale disappeared time of A group and B group ware earlier than those of C group.And the effect of B group was better than C group. Conclusion Ambroxol(A group)or budesonide jointed ambroxol(B group)in the treatment of neonatal aspiration pneumonia has achieved better clinical results,and improved the clinical signs and symptoms,the medication is safe and reliable,which will help the quick recovery of the children.
